+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

HIV-associated Lipodystrophy - Pipeline Insight, 2024 - Product Thumbnail Image

HIV-associated Lipodystrophy - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Cutaneous Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Cutaneous Ulcers - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiation-induced Esophagitis - Pipeline Insight, 2024 - Product Thumbnail Image

Radiation-induced Esophagitis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Functional Dyspepsia - Pipeline Insight, 2024 - Product Thumbnail Image

Functional Dyspepsia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Diabetic Hypoglycemia - Pipeline Insight, 2024 - Product Thumbnail Image

Diabetic Hypoglycemia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chemotherapy-Induced Diarrhea - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy-Induced Diarrhea - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Intestinal Mucosal Injury - Pipeline Insight, 2024 - Product Thumbnail Image

Intestinal Mucosal Injury - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Postoperative Nausea and Vomiting - Pipeline Insight, 2024 - Product Thumbnail Image

Postoperative Nausea and Vomiting - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Chronic Norovirus Enteritis - Pipeline - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Norovirus Enteritis - Pipeline - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Congenital Diarrheal Disorders - Pipeline Insight, 2024 - Product Thumbnail Image

Congenital Diarrheal Disorders - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2024 - Product Thumbnail Image

Postoperative Gastrointestinal Dysfunction - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Digestive System Fistula - Pipeline Insight, 2024 - Product Thumbnail Image

Digestive System Fistula - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gastro Intestinal Bleeding - Pipeline Insight, 2024 - Product Thumbnail Image

Gastro Intestinal Bleeding - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Intestinal Obstruction - Pipeline Insight, 2024 - Product Thumbnail Image

Intestinal Obstruction - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Mallory-weiss Tear - Pipeline Insight, 2024 - Product Thumbnail Image

Mallory-weiss Tear - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Oral Dysplasia - Pipeline Insight, 2024 - Product Thumbnail Image

Oral Dysplasia - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Overactive Bowel Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Overactive Bowel Disease - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Radiotherapy Induced Oral Mucositis - Pipeline Insight, 2024 - Product Thumbnail Image

Radiotherapy Induced Oral Mucositis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Zollinger Ellison Syndrome - Pipeline Insight, 2024 - Product Thumbnail Image

Zollinger Ellison Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Octreotide Market Size, Forecast, and Market Insight - 2032 - Product Thumbnail Image

Octreotide Market Size, Forecast, and Market Insight - 2032

  • Report
  • April 2024
  • 30 Pages
  • Global
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more